# K252495: Lssa (NP-200)

- Pathway: 510(k) (Traditional)
- Applicant: Newpong Co., Ltd.
- Decided: Apr 3, 2026 after 238 days
- Product code: QPB (System, Suction, Lipoplasty For Removal)
- Device class: 2
- Regulation: 21 CFR 878.5040
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 7 generations back to K910696 (1991). 22 ancestors in all.
No later device cites it as a predicate yet.
0 of 23 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K212969: Liposaver, Lhbiomed Co., Ltd. (2024) Summary page 5.

## Indications for use
LSSA is intended for the fragmentation and emulsification of subcutaneous fatty tissues for aesthetic body contouring. LSSA is indicated for use in the following surgical specialists when the fragmentation and aspiration of adipose tissue is desired: - Plastic and Reconstruction Surgery - Orthopedic Surgery

Source page: https://510kreport.com/device/K252495
Methodology: https://510kreport.com/methodology